On 25th March, EMA issued a draft guidance for consultation with deadline for comments on 25th April. https://www.ema.europa.eu/en/documents/scientific-guideline/points-consider-implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical_en.pdfRead More "Draft points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials"
On 20th of March, The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA) have published new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic. The impact of the pandemic on European health systems and more broadly […]Read More "Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic"
The BeCRO board is looking forward to celebrate its 10th anniversary together with ACRON celebrating its 25th anniversary at the EUCROF conference in 2020! ORGANIZERS: EUCROF AFCRO BECRO DATE: FEBRUARY 10, 2020 – FEBRUARY 11, 2020Read More "SAVE THE DATE! JOINED EUCROF, ACRON & BECRO 5TH EUROPEAN CONFERENCE ON CLINICAL RESEARCH"
Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019 Date & Time: 17 April 2019 from 3:30 PM to 5:00 PM (CET) Attendance Fee: € 90,- for EUCROF non-members € 60,- for EUCROF members using the code DATA0417 Register hereRead More "Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019"
SAVE THE DATES BLOCKCHAIN IN CLINICAL TRIALS – HYPE OR REALITY ? * June 21, 2019 BLOCKCHAIN IN CLINICAL TRIALS – HYPE OR REALITY? Blockchain in Clinical Trials- How and Why Blockchain and Distributed Ledger Technologies (DLTs) are new disruptive approaches in the Clinical Trials Industry? For the last 2 years, multiple initiatives are moving […]Read More "BLOCKCHAIN IN CLINICAL TRIALS – HYPE OR REALITY?"
Direct to Patient (D2P) shipment for Clinical Trials – Survey Dear Sponsor, CRO, Investigator or Patient, Within Europe and more specifically within Belgium, Direct To Patient (D2P) shipments have limitations within the current regulatory framework. Considering the growing enthusiasm of pharma companies, investigators and patients performing D2P shipments in the US, we need to investigate […]Read More "Direct to Patient (D2P) shipment for Clinical Trials – Survey"
Virtual Clinical Trials and Direct to Patient Shipments BeCRO has set up and coordinates, with the cabinet of Maggie De Block, FAMHP, FlandersBio, BioWin, Lifetech Brussels, BRAS and several top Pharma companies, a lobbying group on “Virtual Clinical trials and Direct to Patient Shipments”. This working group has conducted a survey on Direct to Patient […]Read More "Virtual Clinical Trials and Direct to Patient Shipments"
BeCRO invited in Tokyo to promote Belgium as a gateway to clinical research in Europe Bruxelles Invest & Export invited BeCRo to present the attractivness of Brussels for clinical trials in the European Union, during the Brussels Days in Tokyo on May 18, 2016. This event was organized on the occasion of celebrating 150 years […]Read More "BeCRO invited in Tokyo to promote Belgium as a gateway to clinical research in Europe"
BeCRO co-organizer of a luncheon event, at BIO 2016 in San Francisco, introduced by Minister Maggie De Block Bio San Francisco on June 7, 2016 : BeCRO co-organized with Bruxelles Invest & Export a luncheon event, introduced by Belgian Federal Minister of Public Health and Social Affairs, Maggie De Block, to reinforce Belgium’s commitment […]Read More "BeCRO co-organizer of a luncheon event, at BIO 2016 in San Francisco"